NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Retractable Technologies Inc. RVP
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$38.3M
▲ 15.8% vs FY2024
EPS · FY25
$-0.43
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-15.6%
Net margin · FY25
-32.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 38.3M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 33 cents on every revenue dollar this year.
Per share
USD -0.43
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-15.6%
Return on equity, FY2025
ROE
Operating margin-55.3%
Net margin-32.8%
Return on assets-8.3%
Each USD of equity lost 16 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−14.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−26.1%
−14.1%
+2.6%
+0.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years−11.8%
Change, 10 years+4.6%
The share count shrank 12% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 142.6M
total assets, end of FY2025
Total assetsUSD 142.6M
EquityUSD 74.4M
CashUSD 2.6M
Gross debtUSD 895,645.00
Net debtUSD -1.7M
Current ratio6.57×
The company holds more cash than debt.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
0.1
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
0.0
0.1
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
Net income $B
−0.0
−0.0
−0.0
0.0
0.1
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
EPS, diluted $
−0.43
−0.40
−0.24
0.15
1.63
0.80
0.07
−0.06
−0.14
−0.15
0.20
−0.12
−0.26
−0.19
0.02
0.04
−0.45
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−15.6
−12.7
−6.8
4.9
75.2
61.8
11.6
−5.1
−13.5
−12.5
15.0
−8.5
−19.3
−11.1
3.7
6.4
−26.2
Shares out B
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed